It is estimated that the Asia-Pacific region will have the highest growth rate in the GLP-1 receptor agonist market with a CAGR of 14.7% in the period between 2026 and 2035 due to the soaring levels of diabetes and obesity, growing healthcare facilities, rising disposable incomes, and increasing awareness of the new advances in diabetes management
Never restart Ozempic at a higher dose than you were previously taking without medical supervision, as dose escalation should always follow the licensed titration schedule to minimise adverse effects
The major electrolytessodium, potassium, chloride, magnesium, calcium, and phosphateregulate fluid balance, maintain acid-base homeostasis, enable nerve signal transmission, facilitate muscle contraction, and support cellular metabolism
Step 2 - Clinician Review
Results In total, 204 cases of SSIBs associated with GLP-1RAs, including semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, were identified in the FAERS database